Results 231 to 240 of about 33,791,512 (292)
History of glucagon-like peptide-1 receptor agonists
Radwan Darwish +2 more
doaj +1 more source
Abstract Purpose To investigate the association between glucagon‐like peptide‐1 receptor agonist (GLP‐1RA) use and nonarteritic anterior ischaemic optic neuropathy (NAION) in type 2 diabetes, examining treatment recency and cumulative duration. Methods This nationwide registry‐based nested case–control study utilizedz Danish health registries (1996 ...
Siar Niazi +9 more
wiley +1 more source
Review Article: Fibrosis‐4 Index in Steatotic Liver Disease—Past, Present and Future
FIB‐4 remains an inexpensive, scalable first‐line triage tool for excluding advanced fibrosis and identifying patients who need second‐line assessment, but it should not be used as a stand‐alone diagnostic or treatment‐selection test. Sequential testing and longitudinal FIB‐4 trajectories may improve risk stratification and prognosis.
Kriti Soni +6 more
wiley +1 more source
Glucagon-Like Peptide-1 Receptor Agonists in Cocaine Use Disorder: Clinical Observations and Underlying Mechanisms. [PDF]
Eiden C +7 more
europepmc +1 more source
Compartmentalisation in cAMP signalling: A phase separation perspective
Cells rely on precise spatiotemporal control of signalling pathways to ensure functional specificity. The compartmentalisation of cyclic AMP (cAMP) and protein kinase A (PKA) signalling enables distinct cellular responses within a crowded cytoplasmic space.
Milda Folkmanaite, Manuela Zaccolo
wiley +1 more source
Association Between Glucagon-Like Peptide-1 Receptor Agonists and Suicidality: A Systematic Review. [PDF]
Chan TH +5 more
europepmc +1 more source
Novel Compounds as Glucagon-Like Peptide‑1 Receptor Agonists for Treating Diabetes. [PDF]
Sabnis RW.
europepmc +1 more source
Glucagon-Like Peptide-1 Targets in the Human Nodose Ganglion. [PDF]
Merchant W +3 more
europepmc +1 more source

